MoneyWorks4Me

The company witnessed a 11.92% growth in the revenue at Rs. 924.03 millions for the quarter ended March 2024 as compared to Rs. 825.60 millions during the year-ago period.Net Profit for the quarter ended March 2024 dipped to Rs. 31.38  millions from Rs. 174.97 millions  in the corresponding previous quarter.Operating Profit saw a handsome growth to 324.54 millions from 260.92 millions in the quarter ended March 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 924.03 825.60 11.92 3654.69 3115.29 17.31 3654.69 3115.29 17.31
Other Income 32.10 28.10 14.23 588.09 98.08 499.60 588.09 98.08 499.60
PBIDT 324.54 260.92 24.38 1639.95 846.96 93.63 1639.95 846.96 93.63
Interest 0.48 0.57 -15.79 1.57 1.35 16.30 1.57 1.35 16.30
PBDT 134.58 260.35 -48.31 1448.90 845.61 71.34 1448.90 845.61 71.34
Depreciation 30.67 27.57 11.24 108.98 102.83 5.98 108.98 102.83 5.98
PBT 103.91 232.78 -55.36 1339.92 742.78 80.39 1339.92 742.78 80.39
TAX 72.53 57.81 25.46 258.69 187.51 37.96 258.69 187.51 37.96
Deferred Tax -2.83 5.52 -151.27 -10.82 4.97 -317.71 -10.82 4.97 -317.71
PAT 31.38 174.97 -82.07 1081.23 555.27 94.72 1081.23 555.27 94.72
Equity 223.65 223.65 0.00 223.65 223.65 0.00 223.65 223.65 0.00
PBIDTM(%) 35.12 31.60 11.13 44.87 27.19 65.05 44.87 27.19 65.05
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..